Skip to main content

Day: February 1, 2022

New step in the sale of La Médicale, Crédit Agricole Assurances’ healthcare professional insurance subsidiary, to Generali

Crédit Agricole Assurances and Generali signed today the sale agreement for La Médicale by Crédit Agricole Assurances to Generali. This operation is accompanied by the sale by Predica1 to Generali Vie of the portfolio of death guarantees marketed by La Médicale. The sale of La Médicale to Generali responds to Crédit Agricole Assurances’ desire to focus on the development of its bancassurance model, a vector of significant synergies with the other entities of the Crédit Agricole group. As a universal bank-insurer and a major player in health, Crédit Agricole Assurances wishes to strengthen its offer in this area to all of its customers via the Group’s local banks. This sale for an amount of €435 million, subject to price adjustments at the time of the sale, is scheduled within 2022. It will have a marginal impact on the solvency of Crédit...

Continue reading

BJ’s Restaurants, Inc. Announces Date for Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call

HUNTINGTON BEACH, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) — BJ’s Restaurants, Inc. (NASDAQ: BJRI) today announced that it will release its fourth quarter and fiscal year 2021 results after the market closes on Thursday, February 17, 2022. The Company will host an investor conference call at 2:00 p.m. (Pacific) that same day. The conference call will be broadcast live over the Internet. To listen to the conference call, please visit the “Investors” page of the Company’s website located at http://www.bjsrestaurants.com several minutes prior to the start of the call to register and download any necessary audio software. An archive of the presentation will be available for 30 days following the call. About BJ’s Restaurants, Inc. BJ’s Restaurants, Inc. (“BJ’s”) is a national brand with brewhouse roots where craft matters. BJ’s broad...

Continue reading

Fantasy 360 Announces Name Change to XR Immersive Tech Inc.

VANCOUVER, British Columbia, Feb. 01, 2022 (GLOBE NEWSWIRE) — Fantasy 360 Technologies Inc. d/b/a Immersive Tech (“Immersive Tech”, “Fantasy 360”, or the “Company”) (CSE:VRAR) (FSE:79W) (OTCQB: FNTTF) is pleased to announce that, it will change its name to XR Immersive Tech Inc. (the “Name Change“), effective as of February 3, 2022. The Company’s stock symbols will remain unchanged. The Company’s new CUSIP is 98383L104 and its new ISIN is CA98383L1040. Tim Bieber, CEO of the Company states, “The Company has been known as “dba Immersive Tech” since its launch in 2017 and we believe the name change to XR Immersive Tech Inc. is more reflective of our overall business and strategic focus on XR (extended reality) experiences for our customers. Now our company name aligns with our overall mission to provide hyper-immersive...

Continue reading

Visualize the Possibilities With the New Trex® AR Decking and Railing Visualizer

Immersive App Enables Users to Preview Deck Designs in Actual EnvironmentsTrex Augmented Reality (AR) Decking and Railing Visualizer App – 1The new Trex® Augmented Reality (AR) Decking and Railing Visualizer tool allows users to explore design possibilities for their outdoor spaces by experimenting with shape, color and material combinations using the full suite of Trex® products against the backdrop of their actual home environments.Trex Augmented Reality (AR) Decking and Railing Visualizer App – 2The new Trex® Augmented Reality (AR) Decking and Railing Visualizer tool allows users to explore design possibilities for their outdoor spaces by experimenting with shape, color and material combinations using the full suite of Trex® products against the backdrop of their actual home environments.WINCHESTER,...

Continue reading

Metromile Announces Stockholder Approval of Merger Agreement with Lemonade

Transaction Anticipated to Close During Q2 2022 SAN FRANCISCO, Feb. 01, 2022 (GLOBE NEWSWIRE) — Metromile (NASDAQ: MILE, MILEW) (the “Company”), a leading digital insurance platform and pay-per-mile auto insurer, announced that at the Special Meeting of Stockholders held today, the Company’s stockholders approved a proposal to adopt the merger agreement entered into with Lemonade, Inc. (NYSE: LMND) to acquire Metromile in an all-stock transaction (the “merger proposal”). The merger proposal was supported by at least 95.9% of the votes cast at the Special Meeting of Stockholders, representing approximately 63.6% of the shares of the Company’s common stock issued and outstanding as of the close of business on December 28, 2021. The final voting results of the Special Meeting, as tabulated by an independent inspector of elections,...

Continue reading

Alchip Technology Moves North America Operation

Upgraded expansion of technical services and business collaborationPhoto 1 of 1 (2107 North First Street)Alchip Technologies has moved its North American headquarters to upgraded facilities in San Jose, just east of the Minneta San Jose International AirportSan Jose, CA, Feb. 01, 2022 (GLOBE NEWSWIRE) — San Jose, CA,  February 1, 2022 – Alchip Technologies, Limited, the high-performance computing ASIC leader, has moved its North American headquarters to upgraded accommodations at 2107 North First Street, San Jose, California. The new facility houses executive offices, business development and account management while accommodating a significant expansion of technical services capabilities. Alchip opened its original offices in October of 2019 and has seen a significant increase in North American contribution to...

Continue reading

22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes

VLN® Menthol King Reduced Nicotine Cigarettes Could Be Exempted from Menthol Ban to Help Current Menthol Smokers Transition Away from Highly Addictive Nicotine CigarettesVLN(R) PackagesVLN(R) Reduced Nicotine Content Cigarettes from 22nd Century GroupBUFFALO, N.Y., Feb. 01, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced its continued support for a menthol ban in nicotine laden combustible cigarettes following FDA’s expectation to publish proposed rules in April 2022. On January 27, 2022, the FDA posted an update on its FDA Voices site stating that it “remains on track” with its plans to prohibit menthol in combustible...

Continue reading

Changes to the Roche Board of Directors and the Corporate Executive Committee

Basel, 1 February 2022 Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that William Pao (1967), M.D., Ph.D., and Head of Roche Pharma Research and Early Development (pRED) since 2018, has decided to leave Roche for a new opportunity and return to the United States, effective 18 March 2022. Johannes (Hans) Clevers (1957), M.D., Ph.D., who joined the Board of Directors in 2019, will step down from this position and be appointed the new Head of Roche pRED effective 18 March 2022. Hans Clevers will become a member of the enlarged Corporate Executive Committee and will be based in Basel. A successor to Hans Clevers’ board position will be identified and announced at a later date. Roche’s CEO Severin Schwan commented: “Having had the opportunity to work closely with Hans Clevers as a member of the Roche Board, I could not be more pleased...

Continue reading

Mastek Appoints Ritwik Batabyal as Chief Technology and Innovation Officer

MastekMastekDALLAS, Feb. 01, 2022 (GLOBE NEWSWIRE) — Mastek, a global digital engineering and cloud transformation specialist, announced the appointment of Ritwik Batabyal as Chief Technology and Innovation Officer. As part of the Vision 2025 roadmap for accelerated growth, Mastek continues to onboard executive leadership talent.  In this role, Ritwik will drive the platforms and non-linear revenue charter which will include innovation-led initiatives that will deliver business value for Mastek’s clients. He will also be responsible to evaluate disruptive technologies, build a cohesive ecosystem of startup partners and create monetization models around AI intersections with industries. This will enable Mastek to provide differentiated business solutions to meet the strategic needs of customers. Commenting...

Continue reading

2021 Spineway fiscal year results : significant improvement and sound dynamic

Press Release         Ecully, February 1st, 2022 – 6 pmFurther improvement on 2021 results27%1 increase in revenue 36% growth in gross margin 26% improvement in operating performance Strategic ambition strengthened by investment capacityIn thousands of euros 2021 2020 % VariationConsolidated accountsConsolidated accounts 4 290 3 379 27%Cost of goods sold – 1 398 – 1 260 -11%Gross Margin 2 892 2 119 36%Turnover %  67,40% 62,70%Operating costs – 4 301 – 4 029 -7%    Including operational costs – 1 941 – 2 269 14%    Including personnel expenses – 2 479 – 2 278 -9%Operating income – 1 409 – 1 910 26%Financial income 223 – 12 279  Including Negma financial one-offs1 0 – 11 978Non-recurring items -397 84  Net income –...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.